Manila Times - sobaoo

Manila Times

Tiny nation targets climate investors to become citizens and help it change the world

Tiny nation targets climate investors to become ci...

4 days ago 4

Lottery.com Regains Nasdaq Compliance as Stock Trading Activity Soars

Lottery.com Regains Nasdaq Compliance as Stock Tra...

4 days ago 6

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

Alterity Therapeutics to Provide Corporate Update ...

4 days ago 7

AGF Investments Announces June 2025 Cash Distributions for Certain AGF ETFs and ETF Series

AGF Investments Announces June 2025 Cash Distribut...

4 days ago 7

SIROCCO BY LEBUA AWARDED TWO FORKS BY GAMBERO ROSSO

SIROCCO BY LEBUA AWARDED TWO FORKS BY GAMBERO ROSS...

4 days ago 9

Flow Capital Announces US$1.5M Follow-On Investment in Tattle

Flow Capital Announces US$1.5M Follow-On Investmen...

4 days ago 7

Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT

Illuccix Approved in U.S. for Patient Selection fo...

4 days ago 8

Evfarmer Announces Approval of MSB License by the U.S. Financial Crimes Enforcement Network (FinCEN)

Evfarmer Announces Approval of MSB License by the ...

4 days ago 5

Attorney Launches Squeaky Clean Solution to Messy RIA Compliance

Attorney Launches Squeaky Clean Solution to Messy ...

4 days ago 5

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

Standard BioTools Enters Next Phase of Transformat...

4 days ago 5

Australia's 'solar godfather': Vietnam leads Southeast Asia's clean energy transition

Australia's 'solar godfather': Vietnam leads South...

4 days ago 5

Cebuana Lhuillier and PSSLAI Enabling Unmatched Financial Access to our Nation's Law Enforcement Personnel

Cebuana Lhuillier and PSSLAI Enabling Unmatched Fi...

4 days ago 6

Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052

Aclaris Therapeutics Initiates Phase 1a/1b Program...

4 days ago 7

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

Cidara Therapeutics Announces Positive Topline Res...

4 days ago 7

Skye Bioscience Shares Nimacimab "Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association's 85th Scientific Sessions

Skye Bioscience Shares Nimacimab "Anatomy of Progr...

4 days ago 5

Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich's Ataxia Program

Larimar Therapeutics Announces FDA Recommendations...

4 days ago 5

Baylin Technologies to Present at the Small Cap Growth Virtual Investor Conference June 26th

Baylin Technologies to Present at the Small Cap Gr...

4 days ago 4

Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD) in Taiwan

Denovo Biopharma LLC Enters into an Exclusive Out-...

4 days ago 4